SK15922001A3 - Deriváty cyklotiokarbamátu ako modulátory receptora pre progesterón - Google Patents

Deriváty cyklotiokarbamátu ako modulátory receptora pre progesterón Download PDF

Info

Publication number
SK15922001A3
SK15922001A3 SK1592-2001A SK15922001A SK15922001A3 SK 15922001 A3 SK15922001 A3 SK 15922001A3 SK 15922001 A SK15922001 A SK 15922001A SK 15922001 A3 SK15922001 A3 SK 15922001A3
Authority
SK
Slovakia
Prior art keywords
substituted
alkyl
group
carbon atoms
dihydro
Prior art date
Application number
SK1592-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Puwen Zhang
Andrew Fensome
Eugene A. Terefenko
Jay E. Wrobel
James P. Edwards
Todd K. Jones
Christopher M. Tegley
Lin Zhi
Mark A. Collins
Original Assignee
American Home Products Corporation
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by American Home Products Corporation, Ligand Pharmaceuticals, Inc. filed Critical American Home Products Corporation
Publication of SK15922001A3 publication Critical patent/SK15922001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1592-2001A 1999-05-04 2000-05-01 Deriváty cyklotiokarbamátu ako modulátory receptora pre progesterón SK15922001A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
SK15922001A3 true SK15922001A3 (sk) 2002-09-10

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1592-2001A SK15922001A3 (sk) 1999-05-04 2000-05-01 Deriváty cyklotiokarbamátu ako modulátory receptora pre progesterón

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Also Published As

Publication number Publication date
GEP20043181B (en) 2004-02-25
PL351083A1 (en) 2003-03-10
IL146298A0 (en) 2002-07-25
HUP0203332A2 (hu) 2003-01-28
JP2002543192A (ja) 2002-12-17
JP5523430B2 (ja) 2014-06-18
EA200101181A1 (ru) 2002-04-25
DK1175411T3 (da) 2008-06-09
NO20015381D0 (no) 2001-11-02
KR20020000170A (ko) 2002-01-04
NO20015381L (no) 2002-01-03
AU766801B2 (en) 2003-10-23
CA2371712C (en) 2009-12-22
DE60038108D1 (de) 2008-04-03
TR200103285T2 (tr) 2002-02-21
SG120970A1 (en) 2006-04-26
NO321370B1 (no) 2006-05-02
DE60038108T2 (de) 2009-02-12
JP4958338B2 (ja) 2012-06-20
EP1175411A1 (en) 2002-01-30
EA004511B1 (ru) 2004-04-29
JP2012087129A (ja) 2012-05-10
MXPA01011287A (es) 2003-07-14
ES2301482T3 (es) 2008-07-01
KR100732692B1 (ko) 2007-06-27
CZ20013952A3 (cs) 2002-05-15
BG106080A (en) 2002-05-31
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
BG65277B1 (bg) 2007-11-30
NZ515353A (en) 2004-03-26
CA2371712A1 (en) 2000-11-09
HUP0203332A3 (en) 2004-12-28
CN1131856C (zh) 2003-12-24
CN1349516A (zh) 2002-05-15
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
US6436929B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
US6509334B1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
JP5523430B2 (ja) プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
US6444668B1 (en) Combination regimens using progesterone receptor modulators
CA2372773A1 (en) Contraceptive compositions containing antiprogestinic and progestinic
AU766428B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators